Form 4: McCormick & Co. Executive Katherine Jenkins Reports Stock Option Grant

Katherine Jenkins, Chief Growth Officer at McCormick & Co., reports the acquisition of stock options.

Summary

• Katherine Jenkins, Chief Growth Officer of McCormick & Co., filed a Form 4 with the SEC.
• The filing reports the grant of options to purchase 19,990 shares of McCormick's voting common stock at an exercise price of $76.03 on March 27, 2024.
• The options vest in thirds over the first three anniversaries of the grant date.
• Following the reported transaction, Jenkins directly owns 3,284 shares of voting common stock, 1,174 shares of non-voting common stock, and options to purchase 19,990 shares of voting common stock.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing. It doesn't inherently convey positive or negative sentiment.

Positives

• The option grant aligns the executive's interests with those of the shareholders, incentivizing her to drive company growth.
• The vesting schedule encourages long-term commitment from the executive.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. Option grants are a common form of executive compensation in publicly traded companies.

Comparison to Industry Standards

• Option grants are a standard component of executive compensation packages in the food and beverage industry, similar to companies like Nestle, Unilever, and Kraft Heinz.
• The vesting schedule of the options (one-third each year for three years) is a typical vesting arrangement.

Stakeholder Impact

• The option grant could potentially impact shareholders by diluting ownership if the options are exercised.
• The option grant incentivizes the Chief Growth Officer, which could benefit shareholders if it leads to increased company performance.

Key Dates